Seattle Genetics Banner Image

Seattle Genetics

  • Ticker SGEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Seattle Genetics Logo Image
  • 501-1000 Employees
  • Based in Bothell, Washington
Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States.
4.8 / 5.0 (158)

Seattle Genetics reports have an aggregate usefulness score of 4.8 based on 158 reviews.

Seattle Genetics

Most Recent Annual Report

Seattle Genetics
MOST RECENT 2022 Annual Report and Form 10K

Seattle Genetics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Seattle Genetics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!